Rxcurve
HCPCS J9394 · per 25 MG

Inj, fulvestrant (fresenius)

This code is not in the latest file (4Q26). It was last listed in 3Q26.

Payment limit per 25 MG, by effective quarter, 1Q23 to 3Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9394

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
3Q26 $27.112 $0.00 25 MG Inj, fulvestrant (fresenius) v1, posted September 15, 2026
2Q26 $27.112 $0.00 25 MG Inj, fulvestrant (fresenius) v1, posted September 15, 2026
1Q26 $27.112 +$0.343 25 MG Inj, fulvestrant (fresenius) v1, posted September 15, 2026
4Q25 $26.769 +$23.447 25 MG Inj, fulvestrant (fresenius) v1, posted September 8, 2026
3Q25 $3.322 $0.00 25 MG Inj, fulvestrant (fresenius) v1, posted March 10, 2026
2Q25 $3.322 −$8.935 25 MG Inj, fulvestrant (fresenius) v1, posted March 10, 2026
1Q25 $12.257 −$40.743 25 MG Inj, fulvestrant (fresenius) v1, posted December 19, 2025
4Q24 $53.00 +$40.743 25 MG Inj, fulvestrant (fresenius) v1, posted June 11, 2025
3Q24 $12.257 +$6.971 25 MG Inj, fulvestrant (fresenius) v1, posted June 11, 2025
2Q24 $5.286 −$47.714 25 MG Inj, fulvestrant (fresenius) v1, posted March 11, 2025
1Q24 $53.00 $0.00 25 MG Inj, fulvestrant (fresenius) v1, posted December 19, 2024
4Q23 $53.00 +$51.347 25 MG Inj, fulvestrant (fresenius) v1, posted October 10, 2024
3Q23 $1.653 −$2.262 25 MG Inj, fulvestrant (fresenius) v1, posted June 5, 2024
2Q23 $3.915 −$3.93 25 MG Inj, fulvestrant (fresenius) v1, posted February 23, 2024
1Q23 $7.845 – 25 MG Inj, fulvestrant (fresenius) v1, posted December 6, 2023

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files